Riccardo Percudani is a Full Professor of Biochemistry at the University of Parma. He graduated with honors in Biological Sciences in 1994 and earned a PhD in Molecular Biology and Pathology from the University of Parma in 1998. His research lies at the interface of biology and informatics, with a particular focus on identifying the functions of genes relevant to human diseases through Big Data analysis and experimental validation.
For the FFC Ricerca Foundation, he conducts research in collaboration with the University of Padua and the Gaslini Institute in Genoa, aimed at developing innovative treatments to reduce inflammatory pathology in cystic fibrosis patients.

Projects funded by FFC Ricerca as Principal Investigator

FFC#14/2022
Actin-resistant acidic DNase for the treatment of CF pulmonary symptoms

Projects financed by FFC Ricerca as a partner

FFC#9/2018
Therapeutic potential of a long-acting lung-specific DNase (DNase2b) for the treatment of CF

Publications from FFC Research projects

• Mori G, Delfino D, Pibiri P, Rivetti C, Percudani R. Origin and significance of the human DNase repertoire. Sci Rep. 2022 Jun 20;12(1):10364. doi: 10.1038/s41598-022-14133-w.
• Delfino D, Mori G, Rivetti C, Grigoletto A, Bizzotto G, Cavozzi C, Malatesta M, Cavazzini D, Pasut G, Percudani R. Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease. Biomolecules. 2021 Mar 10;11(3):410. doi: 10.3390/biom11030410.